Related references
Note: Only part of the references are listed.Association between STAT3 mutations and phenotypic features in Hyper-IgE Syndrome
Marcos R. Goncalves et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia
Sebastian Kollmann et al.
LEUKEMIA (2019)
Structural and functional consequences of the STAT5BN642H driver mutation
Elvin D. de Araujo et al.
NATURE COMMUNICATIONS (2019)
DNA methylation profiling of hepatosplenic T-cell lymphoma
Anke K. Bergmann et al.
HAEMATOLOGICA (2019)
A functional in vitro assay for screening inhibitors of STAT5B phosphorylation
Elvin D. de Araujo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
Nicholas C. P. Cross et al.
LEUKEMIA (2019)
CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis
Qianhui Luo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
STAT5B(N642H) is a driver mutation for T cell neoplasia
Ha Thi Thanh Pham et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
E. I. Andersson et al.
LEUKEMIA (2018)
Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
Constance Baer et al.
HAEMATOLOGICA (2018)
STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia
Min Shi et al.
HUMAN PATHOLOGY (2018)
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Bettina Wingelhofer et al.
LEUKEMIA (2018)
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
Bettina Wingelhofer et al.
LEUKEMIA (2018)
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
Olli Dufva et al.
NATURE COMMUNICATIONS (2018)
Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation
Juergen Klammt et al.
NATURE COMMUNICATIONS (2018)
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
A. Schrader et al.
NATURE COMMUNICATIONS (2018)
Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
Constance Baer et al.
HAEMATOLOGICA (2018)
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Tammy Linlin Song et al.
BLOOD (2018)
STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells
Daniel Ribeiro et al.
BLOOD ADVANCES (2018)
Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA
Li Yao et al.
BLOOD (2018)
Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea
Chi A. Ma et al.
BLOOD (2017)
Novel Mutation in SH2 Domain of STAT3 (p.M660T) in Hyper-IgE Syndrome with Sterno-Clavicular and Paravertebral Abscesses
Biman Saikia et al.
INDIAN JOURNAL OF PEDIATRICS (2017)
High-throughput thermofluor-based assays for inhibitor screening of STAT SH2 domains
Elvin D. de Araujo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
The Genetic Basis of Hepatosplenic T-cell Lymphoma
Matthew McKinney et al.
CANCER DISCOVERY (2017)
STAT3 mutation impacts biological and clinical features of T-LGL leukemia
Antonella Teramo et al.
ONCOTARGET (2017)
Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b
Nagarajan Elumalai et al.
SCIENTIFIC REPORTS (2017)
Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis
Julien Calderaro et al.
MODERN PATHOLOGY (2016)
Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome
Claire E. Bocchini et al.
BLOOD (2016)
Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia
Marcia Bellon et al.
BLOOD (2016)
High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia
Emma I. Andersson et al.
BLOOD (2016)
Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors
Vincent-Philippe Lavallee et al.
BLOOD (2016)
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
Cristina Lopez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities
Ahmed M. Ali et al.
CHEMMEDCHEM (2016)
STAT5B deficiency: Impacts on human growth and immunity
Vivian Hwa
GROWTH HORMONE & IGF RESEARCH (2016)
Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
Piers Blombery et al.
HAEMATOLOGICA (2016)
Distinct mutations at the same positions of STAT3 cause either loss or gain of function
Prabha Chandrasekaran et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Identification of Gene Mutations and Fusion Genes in Patients with Sezary Syndrome
Aparna Prasad et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma
M-L Nairismagi et al.
LEUKEMIA (2016)
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations
Annalisa Roberti et al.
NATURE COMMUNICATIONS (2016)
Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
Piers Blombery et al.
HAEMATOLOGICA (2016)
Primary CNS T-cell Lymphomas A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis
Madhu P. Menon et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
STAT3: too much may be worse than not enough!
Elie Haddad
BLOOD (2015)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome
Camila D. Odio et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
An SH2 domain model of STAT5 in complex with phospho-peptides define STAT5 Binding Signatures''
Eleonora Gianti et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2015)
Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
Lara Brambilla et al.
MOLECULAR ONCOLOGY (2015)
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang et al.
NATURE GENETICS (2015)
Integrated molecular analysis of adult T cell leukemia/lymphoma
Keisuke Kataoka et al.
NATURE GENETICS (2015)
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome
Mark J. Kiel et al.
NATURE COMMUNICATIONS (2015)
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Kucuk et al.
NATURE COMMUNICATIONS (2015)
Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia
Xiaolin Ma et al.
CANCER GENETICS (2015)
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia
Dana V. Babushok et al.
CANCER GENETICS (2015)
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Joshua D. Milner et al.
BLOOD (2015)
How Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5
Florent Langenfeld et al.
PLOS ONE (2015)
Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma
Haley M. Simpson et al.
PLOS ONE (2015)
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
Mark J. Kiel et al.
BLOOD (2014)
STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia
Fumihiro Ishida et al.
CANCER SCIENCE (2014)
STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression
Robert S. Ohgami et al.
HAEMATOLOGICA (2014)
The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse
Obul R. Bandapalli et al.
HAEMATOLOGICA (2014)
A Negative Feedback Loop Mediated by STAT3 Limits Human Th17 Responses
Harriet A. Purvis et al.
JOURNAL OF IMMUNOLOGY (2014)
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next-Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia
Thomas Kristensen et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas
A. Nicolae et al.
LEUKEMIA (2014)
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
M. Kontro et al.
LEUKEMIA (2014)
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
Sarah E. Flanagan et al.
NATURE GENETICS (2014)
STAT3 exon 21 mutation is rare in common human cancers
Min Sung Kim et al.
ACTA ONCOLOGICA (2013)
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
Hanna L. M. Rajala et al.
BLOOD (2013)
Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography
Edwin Nkansah et al.
FEBS LETTERS (2013)
STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model
Lucile Couronne et al.
HAEMATOLOGICA (2013)
Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8+ T-cell memory formation and function
Megan L. Ives et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Lung Parenchyma Surgery in Autosomal Dominant Hyper-IgE Syndrome
Alexandra F. Freeman et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia
Zhi-Yuan Qiu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Severe Growth Deficiency is Associated with STAT5b Mutations that Disrupt Protein Folding and Activity
Benjamin Varco-Merth et al.
MOLECULAR ENDOCRINOLOGY (2013)
STAT3 mutations are highly specific for large granular lymphocytic leukemia
A. Fasan et al.
LEUKEMIA (2013)
STAT3 mutations are frequent in CD30+T-cell lymphomas and T-cell large granular lymphocytic leukemia
R. S. Ohgami et al.
LEUKEMIA (2013)
Clinical Features, STAT3 Gene Mutations and Th17 Cell Analysis in Nine Children with Hyper-IgE Syndrome in Mainland China
L. -Y. Zhang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome
Trine H. Mogensen et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
Sina Haftchenary et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
STAT5b in LGL leukemia - a novel therapeutic target?
Hanna L. M. Rajala et al.
ONCOTARGET (2013)
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia
Andres Jerez et al.
BLOOD (2012)
Functional STAT3 deficiency compromises the generation of human T follicular helper cells
Cindy S. Ma et al.
BLOOD (2012)
The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction
Bernard A. Liu et al.
FEBS LETTERS (2012)
STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway
Jianxin He et al.
JOURNAL OF BIOSCIENCES (2012)
Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome Molecular, Cellular, and Clinical Features From a French National Survey
Marie-Olivia Chandesris et al.
MEDICINE (2012)
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Hanna L. M. Koskela et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The STAT5b pathway defect and autoimmunity
Takahiro Kanai et al.
FRONTIERS IN IMMUNOLOGY (2012)
Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism
Myunggi Baik et al.
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2011)
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
Wolfgang Warsch et al.
BLOOD (2011)
Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)
Jennifer Heimall et al.
CLINICAL IMMUNOLOGY (2011)
SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function
Mauro Giacomelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S)
Jin-yan Liu et al.
EUROPEAN JOURNAL OF PEDIATRICS (2011)
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
Camilla Pilati et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Self-regulation of Stat3 activity coordinates cell-cycle progression and neural crest specification
Massimo Nichane et al.
EMBO JOURNAL (2010)
Frequent STAT3 activation is associated with Mcl-1 expression in nasal NK-cell lymphoma
M. Tsutsui et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2010)
Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis
Lena F. Schimke et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome
Cristina Woellner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Rapid Molecular Analysis of the STAT3 Gene in Job Syndrome of Hyper-IgE and Recurrent Infectious Diseases
Attila Kumanovics et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Acute promyelocytic leukemia harboring a STAT5B-RARA fusion gene and a G596V missense mutation in the STAT5B SH2 domain of the STAT5B-RARA
Eisaku Iwanaga et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML
Annahita Sallmyr et al.
BLOOD (2008)
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells
Laura Passerini et al.
INTERNATIONAL IMMUNOLOGY (2008)
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome
Ellen D. Renner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Cindy S. Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups
Hong Jiao et al.
MOLECULAR IMMUNOLOGY (2008)
STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression
Qian Zhang et al.
NATURE MEDICINE (2007)
STAT3 mutations in the hyper-IgE syndrome
Steven M. Holland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells
Nicholas Chiorazzi
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases
Alireza Mirmohammadsadegh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation
Andrea Hoelbl et al.
BLOOD (2006)
Aberrant folding of a mutant Stat5b causes growth hormone insensitivity and proteasomal dysfunction
DJ Chia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
Q Xu et al.
ONCOGENE (2005)
Structural bases of unphosphorylated STAT1 association and receptor binding
X Mao et al.
MOLECULAR CELL (2005)
Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation
Y Cui et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Identification of the linker-SH2 domain of STAT as the origin of the SH2 domain using two-dimensional structural alignment
Q Gao et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Growth hormone insensitivity associated with a STAT5b mutation
EM Kofoed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
All-trans retinoic acid in acute promyelocytic leukaemia
G Avvisati et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2003)
Share Paper
